Top Story

Cancer screenings common among those with shortest life expectancies

August 18, 2014

A substantial proportion of older Americans with limited life expectancies undergo routine cancer screening despite the unlikely benefit of the tests in this population, according to study results.

“These results raise concerns about overscreening in these individuals, which not only increases health care expenditure but can lead to patient net harm,” Trevor J. Royce, MD, MS, of the University of North Carolina at Chapel Hill, and colleagues wrote.

FDA News

Prescription drug wholesaler pleads guilty to smuggling counterfeit cancer drugs

August 17, 2014
The FDA recently reported that the owner of a Turkish drug wholesaler has pleaded guilty to charges of smuggling misbranded and adulterated cancer treatment drugs into…
figure FDA approvals

FDA approves Avastin for treatment of advanced cervical cancer

August 14, 2014
The FDA today approved bevacizumab for use in combination with chemotherapy for treatment of women with metastatic, recurrent or persistent cervical cancer, according to…
In the JournalsPerspective

Higher BMI increased risk for 10 common cancers

August 13, 2014
Higher BMI increased individuals’ risks for 10 common cancers, according to results of a population-based cohort study conducted in the United Kingdom.More than…
CME

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates

This activity is supported by an educational grant from Merck & Co., Inc.

8/16/2014
Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »
CME

Applying Imaging, Biomarkers, and Immunotherapy in the Management of NSCLC

This activity is supported by an educational grant from Genentech, Inc.

8/7/2014
Non-small cell lung cancer (NSCLC) is the most common form of lung cancer, but the numerous subtypes make this disease…
More »

Filter By:

figure In the Journals

Cancer screenings common among those with shortest life expectancies

August 18, 2014
A substantial proportion of older Americans with limited life expectancies undergo routine cancer screening despite the unlikely benefit of the tests…
FDA News

Prescription drug wholesaler pleads guilty to smuggling counterfeit cancer drugs

August 17, 2014
The FDA recently reported that the owner of a Turkish drug wholesaler has pleaded guilty to charges of smuggling misbranded and adulterated cancer…
figure FDA approvals

FDA approves Avastin for treatment of advanced cervical cancer

August 14, 2014
The FDA today approved bevacizumab for use in combination with chemotherapy for treatment of women with metastatic, recurrent or persistent cervical…
In the Journals Perspective

Higher BMI increased risk for 10 common cancers

August 13, 2014
Higher BMI increased individuals’ risks for 10 common cancers, according to results of a population-based cohort study conducted in the United…
figure In the Journals

European Commission approves Avastin for platinum resistant ovarian cancer

August 7, 2014
The European Commission approved bevacizumab in combination with paclitaxel, topotecan or pegylated liposomal doxorubicin chemotherapy as treatment…
In the Journals Perspective

Smoking habits persisted among cancer survivors

August 6, 2014
Nearly one-tenth of cancer survivors continued to smoke 9 years after diagnosis, according to results of a population-based study.Among that group…
In the Journals

Federal screening program reduced cervical cancer-related mortality in low-income women

July 29, 2014
The National Breast and Cervical Cancer Early Detection Program decreased cervical cancer-related deaths among low-income, medically underrepresented…
figure Cover Stories Publication Exclusive

Liquid biopsies provide extensive information, but technology carries ‘potential for overuse’

HemOnc Today, July 25, 2014
Researchers have known for decades that tumors shed cells and DNA into the bloodstream.
In the Journals

Researchers establish prevalence of uterine cancer at time of hysterectomy with morcellation

July 22, 2014
A database analysis established for the first time the prevalence of uterine cancers among women at the time they undergo minimally invasive…
FDA News

FDA grants priority review for Avastin for treatment of platinum-resistant ovarian cancer

July 22, 2014
The FDA has granted priority review status to bevacizumab plus chemotherapy for the treatment of women with recurrent platinum-resistant ovarian…
More Headlines »